Addex Therapeutics Ltd
Price Action
Technical Summary
WEAKENINGAddex Therapeutics Ltd is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 27), showing significant lag compared to the market leaders. Earnings growth of 11% provides fundamental context to the price action. Investors should exercise caution due to high volatility (88% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.83 | +0.33% | ABOVE |
| 50 SMA | $6.72 | +1.96% | ABOVE |
| 100 SMA | $7.29 | -6.07% | BELOW |
| 150 SMA | $7.77 | -11.84% | BELOW |
| 200 SMA | $7.95 | -13.85% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ADXN in an uptrend right now?
ADXN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ADXN overbought or oversold?
ADXN's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is ADXN outperforming the market?
ADXN has a Relative Strength (RS) Rating of 27 out of 99. ADXN is currently lagging the broader market.
Where is ADXN in its 52-week range?
ADXN is trading at $6.85, which is 57% of its 52-week high ($12.05) and 22% above its 52-week low ($5.41).
How volatile is ADXN?
ADXN has a Beta of 0.59 and 52-week volatility of 88%. It's less volatile than the S&P 500 - generally more stable.